214 related articles for article (PubMed ID: 19366357)
1. Protein-protein interactions: a simple strategy to identify binding sites and peptide antagonists.
Sandomenico A; Monti SM; Sabatella M; De Capua A; Tornatore L; Doti N; Viparelli F; Dathan NA; Pedone C; Ruvo M; Marasco D
Chem Biol Drug Des; 2009 May; 73(5):483-93. PubMed ID: 19366357
[TBL] [Abstract][Full Text] [Related]
2. Generation and functional characterization of a BCL10-inhibitory peptide that represses NF-kappaB activation.
Marasco D; Stilo R; Sandomenico A; Monti SM; Tizzano B; de Capua A; Varricchio E; Liguoro D; Zotti T; Formisano S; Ruvo M; Vito P
Biochem J; 2009 Aug; 422(3):553-61. PubMed ID: 19538180
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the C-terminal SH3 domain of the adaptor protein GADS in complex with SLP-76 motif peptide reveals a unique SH3-SH3 interaction.
Dimasi N
Int J Biochem Cell Biol; 2007; 39(1):109-23. PubMed ID: 17010654
[TBL] [Abstract][Full Text] [Related]
4. Discovery of small peptide antagonists of PED/PEA15-D4α interaction from simplified combinatorial libraries.
Scognamiglio PL; Doti N; Grieco P; Pedone C; Ruvo M; Marasco D
Chem Biol Drug Des; 2011 May; 77(5):319-27. PubMed ID: 21294846
[TBL] [Abstract][Full Text] [Related]
5. Protein-peptide interactions adopt the same structural motifs as monomeric protein folds.
Vanhee P; Stricher F; Baeten L; Verschueren E; Lenaerts T; Serrano L; Rousseau F; Schymkowitz J
Structure; 2009 Aug; 17(8):1128-36. PubMed ID: 19679090
[TBL] [Abstract][Full Text] [Related]
6. Order and disorder in large multi-site docking proteins of the Gab family--implications for signalling complex formation and inhibitor design strategies.
Simister PC; Feller SM
Mol Biosyst; 2012 Jan; 8(1):33-46. PubMed ID: 21935523
[TBL] [Abstract][Full Text] [Related]
7. PDZ domains: folding and binding.
Jemth P; Gianni S
Biochemistry; 2007 Jul; 46(30):8701-8. PubMed ID: 17620015
[TBL] [Abstract][Full Text] [Related]
8. Self-oligomerization of the CARD domain prevents complex formation in the CARMA1 signalosome.
Park JH; Bae JY; Park HH
Int J Mol Med; 2013 May; 31(5):1280-7. PubMed ID: 23525237
[TBL] [Abstract][Full Text] [Related]
9. DARPin-assisted crystallography of the CC2-LZ domain of NEMO reveals a coupling between dimerization and ubiquitin binding.
Grubisha O; Kaminska M; Duquerroy S; Fontan E; Cordier F; Haouz A; Raynal B; Chiaravalli J; Delepierre M; Israël A; Véron M; Agou F
J Mol Biol; 2010 Jan; 395(1):89-104. PubMed ID: 19854204
[TBL] [Abstract][Full Text] [Related]
10. The structure of FADD and its mode of interaction with procaspase-8.
Carrington PE; Sandu C; Wei Y; Hill JM; Morisawa G; Huang T; Gavathiotis E; Wei Y; Werner MH
Mol Cell; 2006 Jun; 22(5):599-610. PubMed ID: 16762833
[TBL] [Abstract][Full Text] [Related]
11. Identification of a novel ubiquitin binding site of STAM1 VHS domain by NMR spectroscopy.
Hong YH; Ahn HC; Lim J; Kim HM; Ji HY; Lee S; Kim JH; Park EY; Song HK; Lee BJ
FEBS Lett; 2009 Jan; 583(2):287-92. PubMed ID: 19111546
[TBL] [Abstract][Full Text] [Related]
12. Design and synthesis of a peptide derived from positions 195-244 of human cdc25C phosphatase.
Morris MC; Mery J; Heitz A; Heitz F; Divita G
J Pept Sci; 1999 Jun; 5(6):263-71. PubMed ID: 10463781
[TBL] [Abstract][Full Text] [Related]
13. The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9.
Kulathila R; Vash B; Sage D; Cornell-Kennon S; Wright K; Koehn J; Stams T; Clark K; Price A
Acta Crystallogr D Biol Crystallogr; 2009 Jan; 65(Pt 1):58-66. PubMed ID: 19153467
[TBL] [Abstract][Full Text] [Related]
14. Structural insights into the association between BCAR3 and Cas family members, an atypical complex implicated in anti-oestrogen resistance.
Garron ML; Arsenieva D; Zhong J; Bloom AB; Lerner A; O'Neill GM; Arold ST
J Mol Biol; 2009 Feb; 386(1):190-203. PubMed ID: 19103205
[TBL] [Abstract][Full Text] [Related]
15. Structural basis of beta-catenin recognition by Tax-interacting protein-1.
Zhang J; Yan X; Shi C; Yang X; Guo Y; Tian C; Long J; Shen Y
J Mol Biol; 2008 Dec; 384(1):255-63. PubMed ID: 18835279
[TBL] [Abstract][Full Text] [Related]
16. The transcriptional repressor RYBP is a natively unfolded protein which folds upon binding to DNA.
Neira JL; Román-Trufero M; Contreras LM; Prieto J; Singh G; Barrera FN; Renart ML; Vidal M
Biochemistry; 2009 Feb; 48(6):1348-60. PubMed ID: 19170609
[TBL] [Abstract][Full Text] [Related]
17. Specificity of molecular interactions in transient protein-protein interaction interfaces.
Cho KI; Lee K; Lee KH; Kim D; Lee D
Proteins; 2006 Nov; 65(3):593-606. PubMed ID: 16948160
[TBL] [Abstract][Full Text] [Related]
18. Truncation and optimisation of peptide inhibitors of cyclin-dependent kinase 2-cyclin a through structure-guided design.
Kontopidis G; Andrews MJ; McInnes C; Plater A; Innes L; Renachowski S; Cowan A; Fischer PM
ChemMedChem; 2009 Jul; 4(7):1120-8. PubMed ID: 19472269
[TBL] [Abstract][Full Text] [Related]
19. Analysis of ligand-dependent recruitment of coactivator peptides to RXRbeta in a time-resolved fluorescence resonance energy transfer assay.
Stafslien DK; Vedvik KL; De Rosier T; Ozers MS
Mol Cell Endocrinol; 2007 Jan; 264(1-2):82-9. PubMed ID: 17184907
[TBL] [Abstract][Full Text] [Related]
20. Structural and functional discussion of the tetra-trico-peptide repeat, a protein interaction module.
Zeytuni N; Zarivach R
Structure; 2012 Mar; 20(3):397-405. PubMed ID: 22404999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
